Shopping Cart
- Remove All
- Your shopping cart is currently empty
RA190 inhibits proteasome function by covalently binding to cysteine 88 of ubiquitin receptor RPN13.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $52 | In Stock | |
5 mg | $117 | In Stock | |
10 mg | $171 | In Stock | |
25 mg | $258 | In Stock | |
50 mg | $460 | In Stock | |
100 mg | $676 | In Stock | |
1 mL x 10 mM (in DMSO) | $153 | In Stock |
Description | RA190 inhibits proteasome function by covalently binding to cysteine 88 of ubiquitin receptor RPN13. |
Targets&IC50 | HeLa cells:0.15 μM |
In vitro | Multiple myeloma (MM) lines, even those resistant to bortezomib, are sensitive to RA190 via endoplasmic reticulum stress-related apoptosis. RA190 stabilizes targets of human papillomavirus (HPV) E6 oncoprotein, and preferentially kills HPV-transformed cells. |
In vivo | RA190 administration profoundly reduces growth of multiple myeloma and ovarian cancer xenografts, and oral RA190 treatment retards HPV16+ syngeneic mouse tumor growth, without impacting spontaneous HPV-specific CD8+ T cell responses. |
Molecular Weight | 596.76 |
Formula | C28H23Cl5N2O2 |
Cas No. | 1617495-03-0 |
Smiles | Cl.N[C@@H](Cc1ccccc1)C(=O)N1C\C(=C\c2ccc(Cl)c(Cl)c2)C(=O)\C(C1)=C/c1ccc(Cl)c(Cl)c1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 95 mg/mL (159.19 Mm) |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.